Cancer Research AACR Conference on Molecular Diagnostics - 2008  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 37, 1099-1104, April 1, 1977]
© 1977 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nomura, T.
Right arrow Articles by Kanzaki, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nomura, T.
Right arrow Articles by Kanzaki, T.

Induction of Urogenital Anomalies and Some Tumors in the Progeny of Mice Receiving Diethylstilbestrol during Pregnancy1

Taisei Nomura2 and Tohru Kanzaki

First Department of Surgery [T. N.] and Institute for Cancer Research [T. N., T. K.], Osaka University Medical School, Fukushima-ku, Osaka 553, Japan

Pregnant mice were given a single dose (10 µg/g body weight) of diethylstilbestrol (DES) on Days 7 to 19, which correspond to the first to fifth lunar months in humans, after the authors, using a 14C-labeled compound, confirmed easy placental penetration by DES. Treatment with DES on Days 15 to 19 resulted in the induction of persistent urogenital sinus (15.8 to 92.5%) and hypertrophy of the portio vaginalis (11.8 to 73.3%) in female offspring, and treatment on Days 17 and 19 resulted in the induction of undescended testes and their hypogenesis (70.4 to 73.3%) in male offspring, although treatment with DES at other stages of pregnancy and after birth did not cause these alterations. The incidence of various tumors (lung adenoma, granulosa cell tumor, etc.) increased significantly (31.0 to 37.9%) when DES was given on Days 15 and 17, which correspond to the stage sensitive to other carcinogens. However, adenosis and adenocarcinoma of the vagina were not observed in the offspring.

1 This paper was prepared at the Department of Genetics (Paper 2080), University of Wisconsin, during the tenure of a Research Training Fellowship awarded from the International Agency for Research on Cancer (WHO). Presented at a seminar of the Rockefeller University in 1974.

2 Present address: Department of Genetics, University of Wisconsin, Madison, Wis. 53706. To whom requests for reprints should be addressed.

Received 7/26/76. Accepted 12/17/76.




This article has been cited by other articles:


Home page
Exp. Biol. Med.Home page
M. Zaleska, A. Waclawik, G. Bodek, A. Zezula-Szpyra, X. Li, T. Janowski, W. H. Hansel, N. A. Rahman, and A. J. Ziecik
Growth Repression in Diethylstilbestrol/Dimethylbenz[a]anthracene-Induced Rat Mammary Gland Tumor Using Hecate-CG{beta} Conjugate
Experimental Biology and Medicine, April 1, 2004; 229(4): 335 - 344.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
K. BLOCK, A. KARDANA, P. IGARASHI, and H. S. TAYLOR
In utero diethylstilbestrol (DES) exposure alters Hox gene expression in the developing mullerian system
FASEB J, June 1, 2000; 14(9): 1101 - 1108.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1977 by the American Association for Cancer Research.